These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 844912)

  • 1. A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma.
    O'Toole C
    Int J Cancer; 1977 Mar; 19(3):324-31. PubMed ID: 844912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.
    O'Toole C; Stejskal V; Perlmann P; Karlsson M
    J Exp Med; 1974 Mar; 139(3):457-66. PubMed ID: 4591169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.
    Perlmann P; Troye M; Pape G; Blomgren H; Johansson B
    Urol Res; 1978; 6(4):207-9. PubMed ID: 741533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay.
    Troye M; Perlmann P; Larsson A; Blomgren H; Johansson B
    Int J Cancer; 1977 Aug; 20(2):188-98. PubMed ID: 892930
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic evaluation of human bladder cancer: in vitro studies.
    Elhilali MM; Nayak SK
    Cancer; 1975 Feb; 35(2):419-31. PubMed ID: 1111918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
    Troye M; Vilien M; Pape GR; Perlmann P
    Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte cytotoxicity against autologous bladder tumor cells in humans, investigated by use of a chromium-51 release assay.
    Jacobsen F
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):175-80. PubMed ID: 7315355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunity to transitional cell carcinoma of the urinary bladder. III. Effects of hydrostatic pressure therapy.
    O'Toole C; Helmstein K; Perlmann P; Moberger G
    Int J Cancer; 1975 Sep; 16(3):413-26. PubMed ID: 1176202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytotoxicity studies in bladder and renal cell cancer.
    Elhilali MM; Nayak SK
    Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH
    Science; 1974 May; 184(4138):795-7. PubMed ID: 4856602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture.
    Pape GR; Troye M; Perlmann P
    J Immunol; 1977 Jun; 118(6):1925-30. PubMed ID: 325130
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET; Ossorio RC; Brosman SA
    Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?
    O'Toole C; Perlmann P; Wigzell H; Unsgaard B; Zetterlund CG
    Lancet; 1973 May; 1(7812):1085-8. PubMed ID: 4123535
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators.
    Moroz C; Madgar I; Twig S; Lindner A; Many M
    Int J Cancer; 1982 Jun; 29(6):667-72. PubMed ID: 6980847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera.
    Schneider MU; Troye M; Paulie S; Perlmann P
    Int J Cancer; 1980 Aug; 26(2):185-92. PubMed ID: 7203712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
    Surg Forum; 1975; 26():122-4. PubMed ID: 56048
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.
    Bubeník J
    Int Urol Nephrol; 1975; 7(4):297-302. PubMed ID: 1107249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer.
    Mizutani Y; Nio Y; Fukumoto M; Yoshida O
    Cancer; 1992 Jan; 69(2):537-45. PubMed ID: 1728384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.